Case presentation: Very early combined first-line immunotherapy and surgery in tumor-associated anti N-methyl-d-aspartate (NMDA) receptor encephalitis associated with improved outcome
Introduction Anti N-methyl-d-aspartate receptor (anti-NMDA-R) encephalitis is a potentially reversible cause of psychosis. Nearly all patients (>95.5%) quickly develop additional neurological symptoms, and only about 50 percent fully recover, often with latency. At symptom onset, patients common...
Main Authors: | S. Witzel, R. Zeiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-03-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823007861/type/journal_article |
Similar Items
-
Catatonia in Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis Misdiagnosed as Schizophrenia
by: André Ponte, et al.
Published: (2020-03-01) -
Case Report: Cotard's Syndrome in Anti-N-methyl D-aspartate (NMDA) Receptor (Anti-NMDAR) Encephalitis
by: Nur Iwana Abdul Taib, et al.
Published: (2022-05-01) -
Psychosis associated with anti-N-methyl-d-aspartate receptor encephalitis
by: Udayan Bhaumik, et al.
Published: (2020-04-01) -
Psychiatric Presentation of Anti-NMDA Receptor Encephalitis
by: Dominique Endres, et al.
Published: (2019-11-01) -
Anti-N-Methyl-d-Aspartate Receptor Encephalitis
by: Te-Yu Hung, et al.
Published: (2011-12-01)